Acta neurobiologiae experimentalis最新文献

Social contagion is a pervasive phenomenon and an important social influence that involves the rapid dissemination (propagation) of behaviors, attitudes, emotions, or ideas from one person to another, often without conscious reflection or rational thought. This phenomenon is closely related to conformity, by which a person changes his/her original ideas and attitude and imitates certain behavior of others. Although some behavioral research has been carried out on contagion and conformity, there is very little neuropsychological understanding of these phenomena. Existing research on social influence and conformity has predominantly focused on tasks like mental rotation or rating tasks involving facial expressions, with fewer studies exploring risk preferences and temporal discounting. However, there is a notable gap in the literature when it comes to examining social influence and conformity using other‑regarding preference models derived from heterodox economics. To address this research gap, the present study investigates the neuropsychological underpinnings of social contagion by utilizing event‑related potentials (ERPs) recorded while subjects engage in mini‑dictator games. The behavioral analysis revealed that contagion had an impact on the participants' preferences, leading to a change in their choices. We observed a P300 component in the midline and right posterior during the time window of 200‑350 ms after stimulus onset, which showed a significant increase in mean amplitude when participants observed others' behavior, compared to when they made decisions based on their own preferences. Moreover, the lack of late positive potential in the time window of 500‑650 ms suggests that the presence of P300 may indicate difficulty in making decisions. In summary, by analyzing both behavioral and ERP data, this study may provide a more comprehensive understanding of the cognitive and neural processes that drive conformity and contagion behavior. Our analysis has the potential to inform policymakers in developing effective interventions for promoting positive social behaviors and reducing negative ones.

The aim of the present study was to evaluate the effect of rosiglitazone (RSG) or pioglitazone (POG) on the synaptic plasticity, neuronal apoptosis, brain-derived neurotrophic factor (BDNF), and nitric oxide (NO) metabolites in the hippocampus of juvenile hypothyroid rats. The animals were divided into four groups: control; propylthiouracil (PTU), 0.05% dose in drinking water for 42 days; PTU-POG; and PTU-RSG. The POG (20 mg/kg) and the RSG (4 mg/kg) were administered by IP injection. We conducted long‑term potentiation (LTP) in the cornu ammonis 1 area of the hippocampus using high‑frequency stimulation of the Schaffer collateral pathway. Then, the hippocampal tissues were collected to determine BDNF and NO levels and the degree of apoptosis. PTU administration decreased the slope (10-90%) and amplitude of the fEPSPs compared to control. Injection of RSG or POG increased the slope, slope (10-90%), and amplitude of the fEPSP in the PTU‑POG or PTU‑RSG groups compared to the PTU group. TUNEL‑positive neurons and NO metabolites in the hippocampus of the PTU group were higher than those of the control group. RSG or POG increased BDNF content in PTU-POG or PTU-RSG groups. Treatment of the rats with POG or RSG decreased apoptotic neurons and NO metabolites in the hippocampus of PTU-POG or PTU-RSG groups, respectively, compared to the PTU group. This study's results revealed that POG or RSG normalized LTP impairment, neuronal apoptosis, and improved BDNF content in the hippocampal tissue of juvenile hypothyroid rats.

Transcranial direct current stimulation (tDCS) is a promising research tool to address substance abuse, including alcohol, tobacco, opioid, and drug use disorders. The present literature review compared previous studies conducted with various current intensities, application regions, durations of stimulations, and different region targets of the brain. Studies based on the analyses conducted after tDCS administration in substance use disorder were promising for the use of tDCS as adjunctive therapy to reduce visible psychological and neurological symptoms of the addiction. Therefore, we aimed to provide an insight into the current state of research on tDCS as a therapeutic intervention in substance use disorders, identify gaps in the literature, and emphasize future investigation areas. Ultimately, the review sought to contribute to the understanding of the role of tDCS in addressing the complex challenges posed by substance use disorder, and its potential as a complementary or adjunctive treatment modality in addiction care. The present study identified that the left dlPFC and brain regions were effective targets for 1 mA and 2 mA tDCS current density in tobacco/nicotine use disorder. Also, the left dlPFC and 2 mA current density were identified as effective targets for tDCS in alcohol use disorder. Furthermore, left dlPFC and 2 mA current density were identified as effective targets for tDCS in opioid use disorder. Additionally, the right/left dlPFC, orbital frontal cortex, thalamus, and 2 mA current density were identified as effective targets for tDCS in other drug or substance use disorders. Animal studies demonstrated that tDCS was promising in reducing neuropathic pain, modulating neuropeptide Y activity, and reducing the redevelopment of ethanol consumption in animal models. However, further research is required to fully understand the optimal tDCS application parameters.